Sharma, Priya
Yadlapati, Rena
Funding for this research was provided by:
national institute of diabetes and digestive and kidney diseases (DK125266)
Article History
First Online: 27 January 2022
Declarations
:
: Rena Yadlapati: Institutional Consulting Agreement: Medtronic, Ironwood Pharmaceuticals, Diversatek; Consultant: Phathom Pharmaceuticals; Research support: Ironwood Pharmaceuticals; Advisory Board with Stock Options: RJS Mediagnostix; Priya Sharma: None.